The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

AMD: The Latest Results from the AREDS2 Study (June 2021)

Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy.  

Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon. 

#Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy  #VisionLoss #LowVision

Business

Medicine

Health & Fitness

Nutrition

Non-Profit

Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy. Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon. #Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision

Share AMD: The Latest Results from the AREDS2 Study (June 2021)

Sign up to save your podcasts

AMD: The Latest Results from the AREDS2 Study (June 2021)

AMD: The Latest Results from the AREDS2 Study (June 2021)

More shows like Macular Chats

Shawn Ryan Show

The Red Light Report

ASGCT Podcast Network

The Ultimate Human with Gary Brecka